Arlington Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20
Closed -$4.55K 154
2023
Q4
$4.55K Hold
20
﹤0.01% 239
2023
Q3
$4.02K Sell
20
-3
-13% -$633 ﹤0.01% 261
2023
Q2
$4.83K Hold
23
﹤0.01% 504
2023
Q1
$4.59K Hold
23
﹤0.01% 468
2022
Q4
$4.71K Hold
23
﹤0.01% 389
2022
Q3
$4K Hold
23
﹤0.01% 345
2022
Q2
$5K Hold
23
﹤0.01% 425
2022
Q1
$5K Sell
23
-26
-53% -$6.12K ﹤0.01% 419
2021
Q4
$13K Buy
+49
New +$12.1K ﹤0.01% 439

Other funds holding LH

Arlington Partners's LH Position: Q1 2024 in Review

Arlington Partners sold out of Labcorp (LH) in Q1 2024, closing a stake of 20 shares — an estimated $4.55K sold.

Arlington Partners first reported a position in LH in Q4 2021 and held it in 9 quarters. The position peaked at $13K in Q4 2021. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Arlington Partners reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Arlington Partners sold 20 Labcorp shares in Q1 2024, an estimated $4.55K.
  • Arlington Partners first reported a position in Labcorp in Q4 2021 and held it in 9 quarters.
  • Arlington Partners's Labcorp position peaked at $13K in Q4 2021.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.